drugset / Trial / NCT02651753
A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337
RandomizedCrossoverOpen-labelTreatment
Summary
This study is a randomized, open-label, single oral dose, 2-way crossover clinical trial to compare safety and pharmacokinetics of CKD-337 in healthy male volunteers.
Timeline
- Start
- 2016-01
- Primary completion
- 2016-03
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 21.7 mg | Oral |
| Subject | CKD-337 | Unknown | 21.7 mg | Oral |
| Subject | CKD-337 | Unknown | 178.8 mg | Oral |
| Subject | Fenofibrate | Small molecule | 160 mg | Oral |